Description
Product Description:
Alectinib is a kinase inhibitor indicated for the treatment of adults with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) who have progressed on crizotinib or are intolerant to crizotinib. patient. Alectinib is indicated as monotherapy for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).
Features:
Product Name Alecinix
Generic name Alectinib
Preparation capsule
Available strength 150 mg
Registerable
Reviews
There are no reviews yet.